直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
    • AI + Finnegan
    • Appeals, Issues, and Legal Strategy
    • Diligence, Licensing, and Opinions
    • Global IP Enforcement, Litigation, and Trials
    • Patent Office Invalidation Proceedings
    • Prosecution and Portfolio Management
    • Trademark and Brand Management
    • AI, Electronics, and Information Technology
    • Chemicals, Industrials, and Materials
    • Communications
    • Consumer Goods and Services
    • Energy
    • Hospitality, Gaming, and Leisure
    • Life Sciences
    • Transportation and Logistics
  • Experience

Experience

Assisted on a successful claim for an Arrow declaration on behalf of a major pharmaceutical company*

Assisted on a successful claim for an Arrow declaration on behalf of a major pharmaceutical company.

Related Professionals

Nessa Khandaker
Associate
London
+44 (0)20 7864 2828
Email

Related Practices

Global IP Enforcement, Litigation, and Trials

Patent Litigation and Trials

Related Industries

Life Sciences

Pharmaceutical

*Matter handled prior to joining Finnegan.

Related Experiences

Arbitration victory for major U.S. pharmaceutical company

Assisted leading multinational consumer electronics corporations in successfully obtaining interim licence declarations in high-profile standard essential patent (SEP) disputes*

Finnegan successfully represents U.S. pharmaceutical company in an arbitration

Global prosecution and portfolio management for major pharmaceutical company

Defended a claim for patent infringement in respect of a number of biotechnology patents on behalf of a molecular diagnostics company*

Ex parte reexamination on behalf of third-party results in PTO rejection of claims

Financial Fusion

Startup sold to major drug company based on strength of patents

Agouron Pharmaceuticals, Inc.

Major media company on the defensive

Advised a global healthcare company in anticipated court proceedings seeking declarations of non-infringement related to its influenza vaccines*

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP